HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

A 1062

inhibits resolvase binding to the res site; structure given in first source

Also Known As:

A-1062

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Coumarins: 826
        A 1062: 2
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Coumarins: 826
        A 1062: 2

Experts

1.	Antoniades, Konstantinos: 1 article (05/2010)
2.	Kitikidou, Kyriaki: 1 article (05/2010)
3.	Kyrgidis, Athanassios: 1 article (05/2010)
4.	Triaridis, Stefanos: 1 article (05/2010)
5.	Tzellos, Thrasivoulos George: 1 article (05/2010)
6.	Vahtsevanos, Konstantinos: 1 article (05/2010)
7.	Xirou, Persa: 1 article (05/2010)
8.	Zouboulis, Christos C: 1 article (05/2010)

Related Diseases

1.	Neoplasms (Cancer) 05/01/2010 - "A 1062 patient-cohort study from a tertiary cancer referral hospital." 01/01/2023 - "A 1062 breast cancer patients with mRNA data and clinical information were obtained from The Cancer Genome Atlas (TCGA). "
2.	Breast Neoplasms (Breast Cancer) 01/01/2023 - "A 1062 breast cancer patients with mRNA data and clinical information were obtained from The Cancer Genome Atlas (TCGA). "

Related Drugs and Biologics

1.	Messenger RNA (mRNA)